Shingles vaccination of adults 50–59 and ≥60 years, U.S.

Details

• Alternative Title:
  Am J Prev Med
• Personal Author:
  Lu, Peng-jun ; Hung, Mei-Chuan ; Srivastav, Anup ; Williams, Walter W. ; Dooling, Kathleen L.
• Description:
  Background:
  
  In 2006, Zoster Vaccine Live (ZVL) was recommended for adults aged ≥60 years. In 2011, ZVL was approved for use, but not recommended, for adults aged 50–59 years.
  
  Purpose:
  
  To assess ZVL coverage among adults aged 50–59 and ≥60 years.
  
  Methods:
  
  Data from the 2013–2017 National Health Interview Surveys (NHIS) were analyzed in 2019 to estimate national ZVL coverage among adults aged ≥50 years. State-specific ZVL coverage among adults aged ≥50 years was assessed using data from the 2017 Behavioral Risk Factor Surveillance System.
  
  Results:
  
  Among adults aged 50–59 years, ZVL coverage was 5.7% in 2017; ranging from 4% to 6% during 2013–2017 (test for trend, p>0.05). ZVL coverage among adults aged 50–59 years ranged from 5.8% in Pennsylvania to 14.7% in South Dakota. By 2017, 34.9% of adults aged ≥60 years received ZVL, a significant increase from 24.2% in 2013. ZVL coverage among adults aged ≥60 years in 2017 ranged from 26.0% in Mississippi to 51.8% in Vermont. In 2017, major characteristics significantly associated with increased likelihood of ZVL vaccination among adults aged 50–59 and ≥60 years were older age, having 4–9 physician contacts in the past 12 months, and having a usual place for health care.
  
  Conclusions:
  
  This study provides an assessment of ZVL coverage among persons aged ≥50 years before the newly recommended Recombinant Zoster Vaccine (RZV) came into widespread use. Providers should routinely assess adults’ vaccination status, strongly recommend or offer needed vaccines to their patients.
  
  
• Subjects:
  Aged Female Herpes Zoster Herpes Zoster Vaccine Humans Male Middle Aged Mississippi Pennsylvania South Dakota Vaccination

  More +
• Keywords:
  Adult Vaccination Coverage Herpes Zoster Recombinant Zoster Vaccine (RZV) Shingles Vaccine Vaccination Zoster Vaccine Live (ZVL)
• Source:
  Am J Prev Med. 59(1):21-31
• Pubmed ID:
  32389533
• Pubmed Central ID:
  PMC9196997
• Document Type:
  Journal Article
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/
• Volume:
  59
• Issue:
  1
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha-512:f884bd20416a39c89af33126a2e9bedbb84b361c4f909490b5ad4a8d656a0eeac1a27d66de67f8d2337d43c06e728cb842dba76f4cfe9aaf4aa1257dbb81534e
• Download URL:
  https://stacks.cdc.gov/view/cdc/119261/cdc_119261_DS1.pdf
• File Type:
  [PDF - 259.72 KB ]